AU599034B2 - Furosemide salts - Google Patents
Furosemide salts Download PDFInfo
- Publication number
- AU599034B2 AU599034B2 AU58890/86A AU5889086A AU599034B2 AU 599034 B2 AU599034 B2 AU 599034B2 AU 58890/86 A AU58890/86 A AU 58890/86A AU 5889086 A AU5889086 A AU 5889086A AU 599034 B2 AU599034 B2 AU 599034B2
- Authority
- AU
- Australia
- Prior art keywords
- furosemide
- salts
- choline
- salt
- ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US751763 | 1985-07-02 | ||
US06/751,763 US4663348A (en) | 1985-07-02 | 1985-07-02 | Furosemide salts and pharmaceutical preparations thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5889086A AU5889086A (en) | 1987-01-08 |
AU599034B2 true AU599034B2 (en) | 1990-07-12 |
Family
ID=25023379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58890/86A Ceased AU599034B2 (en) | 1985-07-02 | 1986-06-16 | Furosemide salts |
Country Status (14)
Country | Link |
---|---|
US (1) | US4663348A (da) |
JP (1) | JPS625975A (da) |
AU (1) | AU599034B2 (da) |
BE (1) | BE904986A (da) |
CH (1) | CH670448A5 (da) |
DE (1) | DE3619665A1 (da) |
DK (1) | DK312586A (da) |
FR (1) | FR2584405B1 (da) |
GB (1) | GB2189239B (da) |
IT (1) | IT1191972B (da) |
LU (1) | LU86484A1 (da) |
NL (1) | NL8601519A (da) |
SE (1) | SE8602917L (da) |
ZA (1) | ZA864207B (da) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU631255B2 (en) * | 1989-10-24 | 1992-11-19 | Roussel-Uclaf | Furosemide salts, preparation process, use as medicaments and pharmaceutical compositions containing them |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4920145A (en) * | 1988-02-29 | 1990-04-24 | Gaf Chemical Corporation | Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof |
EP0569586B1 (en) * | 1991-12-03 | 1996-04-10 | Kokuyo Kabushiki Kaisha | Filing device openable/closable on both sides |
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US7214711B2 (en) * | 1998-12-23 | 2007-05-08 | Neurotherapeutics Pharma Llc | Method of treating migraine headache without aura |
US8008283B2 (en) * | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
FI114538B (fi) * | 2001-01-12 | 2004-11-15 | Finnfeeds Finland Ltd | Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen |
US6989386B2 (en) * | 2002-04-30 | 2006-01-24 | Dana-Farber Cancer Institute | Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
MX2012009323A (es) * | 2010-02-10 | 2012-11-21 | Kissei Pharmaceutical | Sal de derivado heterociclico condensado y cristal del mismo. |
WO2014165660A1 (en) * | 2013-04-05 | 2014-10-09 | Scpharmaceuticals, Llc | Pharmaceutical formulations for subcutaneous administration of furosemide |
WO2020141224A1 (en) | 2019-01-04 | 2020-07-09 | Sq Innovation Ag | Pharmaceutical compositions of furosemide and uses thereof |
CA3128033A1 (en) | 2019-01-31 | 2020-08-06 | Scpharmaceuticals Inc. | Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3058882A (en) * | 1959-12-28 | 1962-10-16 | Hoechst Ag | N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof |
US3565920A (en) * | 1966-12-29 | 1971-02-23 | Ciba Geigy Corp | 5-sulfamyl-anthranilic acids |
DK138322B (da) * | 1970-07-13 | 1978-08-14 | Dumex Ltd As | Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater. |
FR2210607A1 (en) * | 1972-12-20 | 1974-07-12 | Aries Robert | 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid |
DE2343218C2 (de) * | 1973-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | Furosemid enthaltende Pellets |
LU74319A1 (da) * | 1976-02-09 | 1977-08-19 | ||
DE3025367A1 (de) * | 1980-07-04 | 1982-01-28 | Hoechst Ag, 6000 Frankfurt | Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung |
-
1985
- 1985-07-02 US US06/751,763 patent/US4663348A/en not_active Expired - Fee Related
-
1986
- 1986-06-05 ZA ZA864207A patent/ZA864207B/xx unknown
- 1986-06-11 NL NL8601519A patent/NL8601519A/nl unknown
- 1986-06-11 DE DE19863619665 patent/DE3619665A1/de not_active Withdrawn
- 1986-06-16 AU AU58890/86A patent/AU599034B2/en not_active Ceased
- 1986-06-20 LU LU86484A patent/LU86484A1/fr unknown
- 1986-06-23 FR FR868609017A patent/FR2584405B1/fr not_active Expired
- 1986-06-23 GB GB08615275A patent/GB2189239B/en not_active Expired
- 1986-06-24 BE BE6/48235A patent/BE904986A/fr not_active IP Right Cessation
- 1986-06-25 IT IT48183/86A patent/IT1191972B/it active
- 1986-06-30 JP JP61151855A patent/JPS625975A/ja active Pending
- 1986-07-01 SE SE8602917A patent/SE8602917L/xx not_active Application Discontinuation
- 1986-07-01 CH CH2639/86A patent/CH670448A5/fr not_active IP Right Cessation
- 1986-07-01 DK DK312586A patent/DK312586A/da not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU631255B2 (en) * | 1989-10-24 | 1992-11-19 | Roussel-Uclaf | Furosemide salts, preparation process, use as medicaments and pharmaceutical compositions containing them |
Also Published As
Publication number | Publication date |
---|---|
US4663348A (en) | 1987-05-05 |
SE8602917D0 (sv) | 1986-07-01 |
ZA864207B (en) | 1987-02-25 |
BE904986A (fr) | 1986-12-24 |
GB2189239B (en) | 1989-02-01 |
DE3619665A1 (de) | 1987-01-08 |
FR2584405B1 (fr) | 1989-02-24 |
DK312586A (da) | 1987-01-03 |
GB2189239A (en) | 1987-10-21 |
DK312586D0 (da) | 1986-07-01 |
LU86484A1 (fr) | 1986-12-02 |
FR2584405A1 (fr) | 1987-01-09 |
NL8601519A (nl) | 1987-02-02 |
IT1191972B (it) | 1988-03-31 |
SE8602917L (sv) | 1987-01-03 |
JPS625975A (ja) | 1987-01-12 |
AU5889086A (en) | 1987-01-08 |
CH670448A5 (da) | 1989-06-15 |
GB8615275D0 (en) | 1986-07-30 |
IT8648183A0 (it) | 1986-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2568401B2 (ja) | 水溶性メグルミン塩及びグルカミン塩、その製造方法並びにこれを含有する医薬組成物 | |
AU599034B2 (en) | Furosemide salts | |
JPS6191116A (ja) | 安定化された注射用ピロキシカム液剤 | |
IE60713B1 (en) | Use of athiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament | |
US4880835A (en) | Oral liquid pharmaceutical compositions of sulindac | |
US4362730A (en) | Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein | |
PT93571B (pt) | Processo para a preparacao do acido (s)-7-(3-amino-1-pirrolidinil)-1-ciclopropil -6-fluoro-1,4-dihidro-4-oxo-1,8-naftiridino-3-carboxilico e de composicoes farmaceuticas que o contem | |
JPS6248678B2 (da) | ||
NL8102362A (nl) | Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan. | |
US4698361A (en) | Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same | |
US4973553A (en) | Salt or organogermanium compound and medicine containing the same | |
SU1122225A3 (ru) | Способ получени кристаллической водорастворимой негигроскопичной этилендиаминовой,моноэтаноламиновой или диэтаноламиновой соли @ -(2-пиридил)-2-метил-4-окси-2 @ -1,2-бензтиазин-3-карбоксамид-1,1-диоксида | |
US4377583A (en) | N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid | |
EP0923932B1 (en) | Composition containing antitumor agent | |
EP0055593B1 (en) | Compositions comprising e-prostaglandins | |
JPH0343251B2 (da) | ||
EP0140492B1 (en) | L-arginine isoxicamate | |
JP3990728B2 (ja) | N−[4−オキソ−2−(1h−テトラゾール−5−イル)−4h−1−ベンゾピラン−8−イル]−4−(4−フェニルブトキシ)ベンズアミドの塩 | |
JPS61210032A (ja) | 抗腫瘍剤 | |
US3728379A (en) | Propoxyphene salts | |
CA2247329C (en) | Composition containing antitumor agent | |
JPS61186392A (ja) | 金化合物 | |
US3074996A (en) | Cyclohexylsulfamic acid salt | |
EP0153171A2 (en) | New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it | |
GB2028320A (en) | Salts of 2,3-dichloro-4-(4- hydroxybenzoyl) phenoxyacetic acid |